KR20140098865A - 파록세틴으로 체온 조절 기능 이상을 치료하는 방법 - Google Patents

파록세틴으로 체온 조절 기능 이상을 치료하는 방법 Download PDF

Info

Publication number
KR20140098865A
KR20140098865A KR1020147020772A KR20147020772A KR20140098865A KR 20140098865 A KR20140098865 A KR 20140098865A KR 1020147020772 A KR1020147020772 A KR 1020147020772A KR 20147020772 A KR20147020772 A KR 20147020772A KR 20140098865 A KR20140098865 A KR 20140098865A
Authority
KR
South Korea
Prior art keywords
paroxetine
composition
pharmaceutically acceptable
acceptable salt
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147020772A
Other languages
English (en)
Korean (ko)
Inventor
파트리시아 앨리슨 튜이즈 리차드
Original Assignee
노벤 테라퓨틱스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39030027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140098865(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노벤 테라퓨틱스, 엘엘씨 filed Critical 노벤 테라퓨틱스, 엘엘씨
Publication of KR20140098865A publication Critical patent/KR20140098865A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020147020772A 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법 Ceased KR20140098865A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/499,586 2006-08-04
US11/499,586 US20080033050A1 (en) 2006-08-04 2006-08-04 Method of treating thermoregulatory disfunction with paroxetine
PCT/US2007/017062 WO2008019010A2 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020097004195A Division KR20090040453A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157032729A Division KR20150132888A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법

Publications (1)

Publication Number Publication Date
KR20140098865A true KR20140098865A (ko) 2014-08-08

Family

ID=39030027

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020147020772A Ceased KR20140098865A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법
KR1020097004195A Ceased KR20090040453A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법
KR1020157032729A Ceased KR20150132888A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020097004195A Ceased KR20090040453A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법
KR1020157032729A Ceased KR20150132888A (ko) 2006-08-04 2007-07-31 파록세틴으로 체온 조절 기능 이상을 치료하는 방법

Country Status (27)

Country Link
US (7) US20080033050A1 (https=)
EP (2) EP2068881B1 (https=)
JP (2) JP5846717B2 (https=)
KR (3) KR20140098865A (https=)
CN (1) CN101505759A (https=)
AU (1) AU2007282065B2 (https=)
BR (1) BRPI0715087A2 (https=)
CA (1) CA2659577C (https=)
CY (2) CY1120867T1 (https=)
DK (2) DK2068881T3 (https=)
ES (2) ES2698207T3 (https=)
HR (2) HRP20181893T1 (https=)
HU (2) HUE040099T2 (https=)
IL (1) IL196844A (https=)
LT (2) LT2719385T (https=)
ME (1) ME00592B (https=)
MX (1) MX2009001275A (https=)
NO (1) NO343176B1 (https=)
NZ (1) NZ574735A (https=)
PL (2) PL2719385T3 (https=)
PT (2) PT2068881T (https=)
RS (2) RS58046B1 (https=)
RU (1) RU2478379C2 (https=)
SG (1) SG176452A1 (https=)
SI (2) SI2719385T1 (https=)
UA (1) UA96770C2 (https=)
WO (1) WO2008019010A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
CN107249615B (zh) * 2015-04-07 2021-02-05 株式会社明治 潮热抑制剂
KR102817311B1 (ko) 2016-09-29 2025-06-09 (주)아모레퍼시픽 젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
JPH0837567A (ja) 1994-07-26 1996-02-06 Olympus Optical Co Ltd 情報記録媒体及び情報再生装置
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
BR9809687A (pt) * 1997-05-29 2000-07-11 Smithkline Beecham Corp Processo novo
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
EA200000890A1 (ru) 1998-03-02 2001-02-26 Эли Лилли Энд Компани Гидрохлорид флуоксетина для уменьшения "приливов" (приступообразных ощущений жара (при климактерическом синдроме))
PL342931A1 (en) 1998-03-16 2001-07-16 Smithkline Beecham Plc Crystalline form of paroxetine
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) * 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) * 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
CA2418038A1 (en) 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
US6498184B2 (en) * 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
NZ526874A (en) * 2001-01-04 2005-07-29 Ferrer Internacional S Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
DE20100529U1 (de) 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
EP1530476A1 (en) * 2002-08-14 2005-05-18 Pharmacia & Upjohn Company LLC Use of reboxetine for the treatment of hot flashes
US20040152710A1 (en) 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) * 2003-01-03 2006-12-01 Lite On It Corp Method to detect the type of optical disk
US20050130987A1 (en) 2003-10-14 2005-06-16 Wyeth Methods of treating vasomotor symptoms
RU2007102292A (ru) * 2004-07-22 2008-08-27 Вайет (Us) Способ лечения расстройств и заболеваний нервной системы
MX2007000851A (es) * 2004-07-22 2007-03-26 Wyeth Corp Procedimiento para el tratamiento de trastornos y dolencias del sistema nervioso.
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
CN101325944B (zh) * 2005-10-11 2013-01-16 耶路撒冷希伯来大学伊萨姆研究开发公司 用于鼻部给药的组合物
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Also Published As

Publication number Publication date
AU2007282065A1 (en) 2008-02-14
CY1120867T1 (el) 2019-12-11
JP2014077023A (ja) 2014-05-01
WO2008019010A2 (en) 2008-02-14
EP2719385A1 (en) 2014-04-16
US20150335631A1 (en) 2015-11-26
MX2009001275A (es) 2009-04-16
RS57980B1 (sr) 2019-01-31
KR20090040453A (ko) 2009-04-24
ME00592A (en) 2011-12-20
US20180036299A1 (en) 2018-02-08
US20170165251A1 (en) 2017-06-15
JP5846717B2 (ja) 2016-01-20
DK2719385T3 (en) 2018-12-10
US8859576B2 (en) 2014-10-14
US20140235674A1 (en) 2014-08-21
ES2699298T3 (es) 2019-02-08
IL196844A0 (en) 2009-12-24
ME00592B (me) 2011-12-20
EP2068881B1 (en) 2018-08-22
PT2068881T (pt) 2018-11-29
JP5895009B2 (ja) 2016-03-30
JP2009545593A (ja) 2009-12-24
US20140249182A1 (en) 2014-09-04
RS58046B1 (sr) 2019-02-28
CA2659577A1 (en) 2008-02-14
HUE040481T2 (hu) 2019-03-28
EP2068881A4 (en) 2009-09-30
DK2068881T3 (en) 2018-12-10
CN101505759A (zh) 2009-08-12
KR20150132888A (ko) 2015-11-26
HRP20181925T1 (hr) 2019-01-11
SG176452A1 (en) 2011-12-29
ES2698207T3 (es) 2019-02-01
EP2068881A2 (en) 2009-06-17
BRPI0715087A2 (pt) 2015-02-10
US20200268733A9 (en) 2020-08-27
RU2478379C2 (ru) 2013-04-10
PL2719385T3 (pl) 2019-06-28
AU2007282065B2 (en) 2013-05-09
SI2719385T1 (sl) 2019-01-31
NO20090639L (no) 2009-02-25
LT2068881T (lt) 2018-12-10
LT2719385T (lt) 2018-12-27
UA96770C2 (uk) 2011-12-12
HUE040099T2 (hu) 2019-02-28
PT2719385T (pt) 2018-12-04
HRP20181893T1 (hr) 2019-01-11
SI2068881T1 (sl) 2019-01-31
US20090275615A1 (en) 2009-11-05
US20080033050A1 (en) 2008-02-07
NZ574735A (en) 2011-03-31
RU2009107739A (ru) 2010-09-10
CA2659577C (en) 2015-11-24
EP2719385B1 (en) 2018-08-29
US9393237B2 (en) 2016-07-19
NO343176B1 (no) 2018-11-26
WO2008019010A3 (en) 2008-12-24
IL196844A (en) 2015-11-30
US8658663B2 (en) 2014-02-25
CY1120902T1 (el) 2019-12-11
PL2068881T3 (pl) 2019-04-30
US8946251B2 (en) 2015-02-03

Similar Documents

Publication Publication Date Title
CA2502027A1 (en) A method of treating vasomotor symptoms comprising a compound having norepinephrine reuptake inhibitor activity and 5-ht2a antagonistic activity
KR20140098865A (ko) 파록세틴으로 체온 조절 기능 이상을 치료하는 방법
CN1674907A (zh) 瑞波西汀在治疗热潮红中的用途
EP1345610B1 (en) Quetiapine for treating of dyskinesia in non-psychotic patients
CN102970991A (zh) 异常性疼痛和痛觉增敏的治疗
HK1196291A (en) Method of treating thermoregulatory disfunction with paroxetine
CN1705475A (zh) 通过具有去甲肾上腺素重摄取抑制剂活性和5－ht2a拮抗活性的化合物治疗血管舒缩症的方法
HK1078778A (en) Use of reboxetine for the treatment of hot flashes

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20140723

Application number text: 1020097004195

Filing date: 20090227

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140820

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141027

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150819

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141027

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20151116

Application number text: 1020097004195

Filing date: 20090227

PJ0201 Trial against decision of rejection

Patent event date: 20151116

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20150819

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2015101006746

Request date: 20151116

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20151119

WITB Written withdrawal of application
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20151116

Effective date: 20160302

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20160302

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20151116

Decision date: 20160302

Appeal identifier: 2015101006746